切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2011, Vol. 05 ›› Issue (04) : 408 -418. doi: 10.3877/cma.j.issn.1674-0807.2011.04.004

临床研究

术中冰冻切片联合快速免疫组织化学染色检测乳腺癌前哨淋巴结微转移的临床研究
席晨辉1, 庄大勇1, 郑鲁明1, 周鹏1, 段松建1, 柳晓建1, 贺青卿1,()   
  1. 1.250031 济南,济南军区总医院甲状腺乳腺外科
  • 收稿日期:2010-11-18 出版日期:2011-08-01
  • 通信作者: 贺青卿
  • 基金资助:
    中国博士后科学基金资助(20080431408)

Clinical research of intraoperative frozen sections plus rapid immunohistochemistry staining in detection of sentinel lymph node micrometastas is of breast cancer

Chenhui XI1, Da-yong ZHUANG1, Lu-ming ZHENG1, Peng ZHOU1, Song-jian DUAN1, Xiao-jian LIU1, Qing-qing HE,1()   

  1. 1.Thyroid Breast Surgery, Jinan Military General Hospital, Jinan 250031,China
  • Received:2010-11-18 Published:2011-08-01
  • Corresponding author: Qing-qing HE
引用本文:

席晨辉, 庄大勇, 郑鲁明, 周鹏, 段松建, 柳晓建, 贺青卿. 术中冰冻切片联合快速免疫组织化学染色检测乳腺癌前哨淋巴结微转移的临床研究[J/OL]. 中华乳腺病杂志(电子版), 2011, 05(04): 408-418.

Chenhui XI, Da-yong ZHUANG, Lu-ming ZHENG, Peng ZHOU, Song-jian DUAN, Xiao-jian LIU, Qing-qing HE. Clinical research of intraoperative frozen sections plus rapid immunohistochemistry staining in detection of sentinel lymph node micrometastas is of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2011, 05(04): 408-418.

目的

探讨术中冰冻切片联合快速免疫组织化学检测对乳腺癌前哨淋巴结(SLN)微转移的诊断价值,分析SLN 微转移与临床各因素的关系。

方法

对43 例乳腺癌患者行前哨淋巴结活检(SLNB),切除SLN 送快速病理学检查。 以100 μm 为间隔,进行连续切片(SS),并做冰冻切片HE 染色及快速免疫组织化学染色检测SLN 微转移[检测广谱细胞角蛋白(pan-CK)及上皮膜抗原(EMA)的表达];采用χ2 检验或连续性校正χ2 检验对定性资料进行统计学分析。

结果

43 例乳腺癌患者成功行SLNB,共检出SLN 100 枚。 4 例冰冻切片HE 染色查见癌转移,39 例HE 染色阴性者继续行快速免疫组织化学染色检出微转移者6 例。 冰冻切片检测SLN 癌转移率为9.3%(4/43),冰冻切片联合术中快速免疫组织化学染色检测SLN 癌转移率为23.3%(10/43)。 两者的灵敏度、特异度、总符合率和假阴性率分别为36.4%/90.9%、100%/100%、83.7%/97.7%、63.6%/9.1%。 SLN 微转移与月经状态、肿瘤分期、组织学类型、肿瘤位置、激素受体状态及人表皮生长因子受体2(HER-2)状态无明显关系(P>0.05)。

结论

术中冰冻切片联合快速免疫组织化学染色法提高了SLN 微转移的检出率,减少了假阴性率,且安全、快速、花费少,值得在临床推广使用。

Objective

To investigate the diagnostic value of intraoperative frozen sections plus rapid immunohistochemistry staining in detecting sentinel lymph nodes(SLNs)micrometastases of breast cancer, and analyse the relation between SLNs micrometastases and clinical factors.

Methods

Forty-three breast cancer patients underwent sentinel lymph node biopsy (SLNB). The intraoperatively resected SLNs were sent for rapid pathological examination. Serial sections at a 100 μm interval, HE staining of frozen sections and rapid immunohistochemistry staining were done to detect SLNs micrometastases and test the expressions of pan-cytokerain(pan-CK) and epithelial membrane antigen (EMA). Chisquare test or correction chi-square test was used for statistical analysis.

Results

SLNB was successful for the 43 breast cancer patients. A total of 100 SLNs were detected. Four cases were detected with cancer metastases by HE staining of frozen sections. Thirty-nine cases with negative HE staining were continuously detected with rapid immunohistochemistry staining examination, of them 6 were detected with micrometastases. The detection rate of SLNs metastases was 9.3%(4/43)by HE staining of frozen sections, but was 23.3%(10/43) by frozen sections plus intraoperative rapid immunohistochemistry staining. The sensitivity,specificity, coincidence rate and false negative rate for HE staining of frozen sections and frozen sections plus intraoperative rapid immunohistochemistry staining were 36.4% and 90.9%, 100% and 100%, 83.7% and 97.7%, and 63.6% and 9.1%, respectively. There was no significant correlation between the SLNs micrometastases and menstrual status, tumor stage, histological type, tumor location, hormone receptor status and HER-2 status(P>0.05).

Conclusion

Intraoperative frozen sections plus rapid immunohistochemistry staining can increase the detection rate of SLNs micrometastases and reduce the false negative rate. It is safe, rapid, and low-costly. We recommend this method in clinical application.

图1 术中解剖前哨淋巴结 术中可清晰辨认蓝染的前哨淋巴结及淋巴管(箭头所示)。
图2 切除后的前哨淋巴结 明确为前哨淋巴结(箭头所示)后,将其连同周围的脂肪组织一并切除。
表1 前哨淋巴结术中冰冻切片HE 染色与联合快速免疫组织化学染色的评价指标比较
表2 临床因素与前哨淋巴结微转移的关系
图3 前哨淋巴结冰冻切片HE 染色阴性(×200) 淋巴细胞形态结构均一,未见病理性核分裂相。
图4 前哨淋巴结冰冻切片HE 染色阳性(×200) 箭头所示,视野中央部分淋巴细胞形态大小不一,细胞异型性明显,病理性核分裂相多,符合转移癌的表现。
图5 免疫组织化学染色检测前哨淋巴结微转移(×200) 箭头所示,淋巴结内转移的癌细胞经细胞角蛋白(CK)-pan 染色后呈阳性表达。
图6 免疫组织化学染色检测孤立性肿瘤细胞(×200) 箭头所示,淋巴结内转移的癌细胞经上皮膜抗原(EMA)染色后呈阳性表达。
[1]
Kumar S,Bramlage M, Jacks LM,et al. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease[J]. Ann Surg Oncol,2010, 17(11):2909-2919.
[2]
Masci G, Di Tommaso L, Del Prato I, et al. Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer[J]. Ann Oncol,2010, 21(6):1228-1232.
[3]
de Boer M,van Dijck JA,Bult P,et al. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells,and micrometastases[J]. J Natl Cancer Inst,2010, 102(6):410-425.
[4]
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol,2010,17(6):1471-1474.
[5]
Klevesath MB, Bobrow LG,Pinder SE,et al.The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer[J]. Br J Cancer,2005, 92(12):2201-2205.
[6]
王燕霞,郭文斌,白艳,等.Ⅰ期乳腺癌淋巴结微小转移检测及其临床意义[J].中国肿瘤临床与康复,2005, 12(2):123.
[7]
Veronesi U, Paganelli G, Viale G,et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series[J]. J Natl Cancer Inst,1999, 91(4):368-373.
[8]
Carlson RW, Craig Allred D, Benjamin O, et al. Clinical Practice Guidelines in Oncology: breast cancer.NCCN,2010[S/OL].[2010-11-01] http:/ /www.nccn.org.
[9]
Chen SL,Hoehne FM,Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population based analysis[J].Ann Surg Oncol,2007,14(12):3378-3384.
[10]
van de Vrande S, Meijer J, Rijnders A,et al. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer[J]. Eur J Surg Oncol,2009,35(3):276-280.
[11]
Krishnamurthy S, Meric Bernstam F, Lucci A,et al.A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer[J]. Cancer,2009,115(7):1555-1562.
[12]
范蕾,穆殿斌,高彦,等.乳腺癌前哨淋巴结微转移检测研究[J/CD].中华乳腺病杂志:电子版,2007,1(5):13-20.
[13]
Falconieri G,Pizzolitto S,Gentile G.Comprehensive examination of sentinel lymph node in breast cancer: a solution without a problem ? [J]. Int J Surg Pathol,2006,14(1):1-8.
[14]
Zhang T,Zhang BN,Chen BP,et al. Detection of micrometastases in sentinel lymph node of breast cancer[J]. Chinese-German J Clin Oncol,2007,6(6):562-565.
[15]
Andersson Y, Frisell J, Sylvan M,et al. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes[J]. J Clin Oncol,2010, 28(17):2868-2873.
[16]
Cox CE,Kiluk JV,Riker AI,et al.Significance of sentinel lymph node micrometastases in human breast cancer[J].J Am Coll Surg,2008,206(2):261-268.
[17]
Hansen NM,Grube B,Ye X,et al.Impact of micrometastases in the sentinel node of patients with invasive breast cancer[J]. J Clin Oncol,2009,27(28):4679-4684.
[18]
Cordero García JM,Delgado Portela M,García Vicente AM,et al.Micrometastasis in the sentinel node and axillary lymph node macrometastasis in breast cancer[J]. Rev Esp Med Nucl,2010,29(3):122-126.
[19]
Lyman G,Giuliano AE,Somerfield MR,et al.American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005,23(30):7703-7720.
[20]
Truong PT,Lesperance M,Li KH,et al. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series[J]. Ann Surg Oncol, 2010,17(8):2138-2146.
[21]
Krauth JS,Charitansky H,Isaac S,et al.Clinical implications of axillary sentinel lymph node ‘micrometastases’ in breast cancer[J]. Eur J Surg Oncol,2006,32(4):400-404.
[22]
Veronesi U, Viale G, Paganelli G,et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study[J]. Ann Surg,2010, 251(4):595-600.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
阅读次数
全文


摘要